Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.699 USD | +2.21% | +1.01% | -50.43% |
Valuation
Fiscal Period: December | 2022 | 2023 | 2024 |
---|---|---|---|
Capitalization 1 | 48.22 | 11.78 | 11.78 |
Enterprise Value (EV) 1 | 48.22 | 11.78 | 11.78 |
P/E ratio | -0.14 x | -1.09 x | -1.49 x |
Yield | - | - | - |
Capitalization / Revenue | - | 0.23 x | 0.18 x |
EV / Revenue | - | 0.23 x | 0.18 x |
EV / EBITDA | - | -3.73 x | -8.69 x |
EV / FCF | - | - | - |
FCF Yield | - | - | - |
Price to Book | - | - | - |
Nbr of stocks (in thousands) | 10,574 | 16,846 | 16,846 |
Reference price 2 | 4.560 | 0.6990 | 0.6990 |
Announcement Date | 4/12/23 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2022 | 2023 | 2024 |
---|---|---|---|
Net sales 1 | - | 51.29 | 63.98 |
EBITDA 1 | - | -3.161 | -1.355 |
EBIT 1 | - | -11.14 | -8.405 |
Operating Margin | - | -21.73% | -13.14% |
Earnings before Tax (EBT) 1 | - | -7.791 | -8.925 |
Net income 1 | -13.83 | -7.746 | -8.525 |
Net margin | - | -15.1% | -13.32% |
EPS 2 | -33.16 | -0.6400 | -0.4700 |
Free Cash Flow | - | - | - |
FCF margin | - | - | - |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 4/12/23 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|
Net sales 1 | - | 13.75 | 14.55 | 15.25 | 16.64 | 17.55 |
EBITDA 1 | - | -1.125 | -0.605 | -0.56 | -0.33 | 0.14 |
EBIT 1 | - | -2.9 | -2.375 | -2.325 | -2.09 | -1.615 |
Operating Margin | - | -21.09% | -16.32% | -15.25% | -12.56% | -9.2% |
Earnings before Tax (EBT) 1 | - | -3 | -2.505 | -2.455 | -2.22 | -1.745 |
Net income 1 | -3.349 | -2.94 | -2.405 | -2.355 | -2.12 | -1.645 |
Net margin | - | -21.38% | -16.53% | -15.44% | -12.74% | -9.37% |
EPS 2 | -0.2700 | -0.2000 | -0.1400 | -0.1400 | -0.1100 | -0.0800 |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 11/20/23 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2022 | 2023 | 2024 |
---|---|---|---|
Net Debt | - | - | - |
Net Cash position | - | - | - |
Leverage (Debt/EBITDA) | - | - | - |
Free Cash Flow | - | - | - |
ROE (net income / shareholders' equity) | - | - | - |
ROA (Net income/ Total Assets) | - | - | - |
Assets 1 | - | - | - |
Book Value Per Share | - | - | - |
Cash Flow per Share | - | - | - |
Capex 1 | - | 1.3 | 1.75 |
Capex / Sales | - | 2.53% | 2.74% |
Announcement Date | 4/12/23 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.43% | 11.78M | |
+21.11% | 72.89B | |
-4.38% | 23.48B | |
+6.11% | 8.51B | |
+10.16% | 8.42B | |
-22.99% | 7.56B | |
+12.88% | 5.22B | |
+0.14% | 4.2B | |
+0.48% | 3.91B | |
+10.84% | 3.91B |
- Stock Market
- Equities
- COSM Stock
- Financials Cosmos Health Inc.